Metamizol Meditop

Metamizole Sodium, the active ingredient in Metamizol Meditop, is a pyrazolone presented as an oral formulation for systemic use. It is employed to relieve pain and reduce fever in adult patients requiring prescription‑only therapy.

GNH USA supplies Metamizol Meditop as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metamizol Meditop, a pyrazolone analgesic and antipyretic, is used in conditions where pain or fever require effective control.

- Pain: provides rapid relief of moderate to severe acute pain. - Fever: reduces elevated body temperature associated with infection or inflammation. - Postoperative pain: helps manage pain following surgical procedures. - Colic: alleviates severe abdominal cramping and discomfort.

Metamizol Meditop may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Vomiting: occasional emesis. - Dizziness: transient light‑headedness. - Hypotension: occasional drop in blood pressure. - Rash: mild skin irritation. - Headache: occasional mild headache.

Serious or Rare Side Effects: - Agranulocytosis: severe reduction in white blood cells. - Aplastic anemia: bone‑marrow failure. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic injury: elevated liver enzymes or hepatitis. - Blood dyscrasias: thrombocytopenia or hemolytic anemia. - Anaphylaxis: life‑threatening allergic reaction.

Before prescribing Metamizol Meditop, consider the following safety measures.

- Assess blood counts: monitor for agranulocytosis during therapy. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Use caution in renal impairment: adjust therapy as needed. - Do not combine with other NSAIDs without supervision: increased risk of gastrointestinal irritation. - Pregnancy and lactation: consult a physician before use. - Store at room temperature: keep in the original pack, protect from moisture.

Metamizol Meditop can interact with several drug classes.

Major Interactions (Avoid): - Myelosuppressive agents: may exacerbate bone‑marrow suppression. - Sulfonamides: increased risk of blood dyscrasias. - Anticoagulants: heightened bleeding tendency.

Moderate Interactions (Monitor Closely): - Other NSAIDs: additive gastrointestinal irritation. - Diuretics: may enhance hypotensive effects. - Alcohol: can increase sedation and dizziness.